モハッメドタレグオマル

モハッメドタレグオマル | Mohammed Tareg Omer

所属機関・部署：
職名： Postdoctoral Researcher

研究分野 (5件)：細菌学 , 構造生物化学 , 腫瘍生物学 , 細胞生物学 , 分子生物学

研究キーワード (7件)： Protein-protein interactions , HS-AFM , Actin cytoskeleton , Nanometrology , Molecular biology , Cancer Biology , Nanobiology

論文 (4件)：

Tareg Omer Mohammed, You-Rong Lin, Kai Weissenbruch, Kien Xuan Ngo, Yanjun Zhang, Noriyuki Kodera, Martin Bastmeyer, Yusuke Miyanari, Azuma Taoka, Clemens M. Franz. S100A11 promotes focal adhesion disassembly via myosin II-driven contractility and Piezo1-mediated Ca2+entry. 2023
Kien Xuan Ngo, Phuong Doan N. Nguyen, Hirotoshi Furusho, Makoto Miyata, Tomomi Shimonaka, Nguyen Ngoc Bao Chau, Nguyen Phuong Vinh, Nguyen Anh Nghia, Tareg Omer Mohammed, Takehiko Ichikawa, et al. Unraveling the Host-Selective Toxic Interaction of Cassiicolin with Lipid Membranes and Its Cytotoxicity. Phytopathology®. 2022. 112. 7. 1524-1536
S100A11 promotes tumorigenesis of NSCLC through cytoskeleton integrity maintenance and YAP activation. 2019
Tareg Omer Mohammed, Haorile Chagan-Yasutan, Yugo Ashino, Wakana Nakayama, Yayoi Takahashi, Taizo Shimomura, Tetsuhiro Fujimoto, Yuko Watanabe, Toshiro Niki, Hitoshi Suzushima, et al. Galectin-9 as a Predictive Marker for the Onset of Immune-Related Adverse Effects Associated with Anti-CCR4 MoAb Therapy in Patients with Adult T Cell Leukemia. The Tohoku Journal of Experimental Medicine. 2017. 241. 3. 201-208

講演・口頭発表等 (4件)：

S100A11 promotes NSCLC tumorigenesis through YAP activation by inducing structural changes in F-actin organization.
(Joint Annual Meeting of 71st JSCB & 19th PSSJ June 2019, Kobe, Japan 2019)
S100A11 facilitates the migratory, invasive, and proliferative capacity of NSCLC.
(The 77th Annual Meeting of the Japanese Cancer Association, 2018, Osaka, Japan. 2018)
Knockdown of S100A11 attenuates aggressive properties of lung adenocarcinoma cells by regulating F-actin organization and lamellipodia formation
(The 72nd meeting of the Japanese Society for Bacteriology, 2018, Sendai, Japan. 2018)
Adult T cell leukemia: Galectin-9 a Potential Immune-marker for Skin Eruption and Immune Reconstitution Inflammatory Syndrome a possible Outcome after Mogamulizumab.
(The 7th JSH International Symposium: Advances in Immunotherapy for Haematological Malignancies, 2016, Awaji, Japan. 2016)

学歴 (3件)：

2015 - 2019 東北大学大学院医学系研究科
2013 - 2015 東北大学大学院医学系研究科
2005 - 2009 Asmara College of Health Sciences Clinical Laboratory Sciences Bachelor

経歴 (3件)：

2020/06 - 現在金沢大学金沢大学ナノ生命科学研究所
2020/01 - 2020/03 東北医科薬科大学
2009/08 - 2013/03 Asmara College of Health Sciences Clinical Laboratory Sciences

受賞 (3件)：

2015/10 - Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan MEXT Scholarship
2013/04 - Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan MEXT Scholarship
2010/07 - Asmara College of Health Sciences, Eritrea. Medal of academic excellence

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

モハッメド タレグオマル